Measurement of persistence and adherence to regimens of IOP-lowering glaucoma medications using pharmacy claims data.
about
Interventions for improving adherence to ocular hypotensive therapyInterventions for improving adherence to ocular hypotensive therapyCombination of brinzolamide and brimonidine for glaucoma and ocular hypertension: critical appraisal and patient focusPharmacoeconomic analysis of prostaglandin and prostamide therapy for patients with glaucoma or ocular hypertension.Costs and persistence of alpha-2 adrenergic agonists versus carbonic anhydrase inhibitors, both associated with prostaglandin analogues, for glaucoma as recorded by The United Kingdom General Practitioner Research Database.Persistence on prostaglandin ocular hypotensive therapy: an assessment using medication possession and days covered on therapy.Treatment persistence and cost-effectiveness of latanoprost/latanoprost-timolol, bimatoprost/bimatoprost-timolol, and travoprost/travoprost-timolol in glaucoma: an analysis based on the United Kingdom general practitioner research databaseComparing treatment persistence, healthcare resource utilization, and costs in adult patients with major depressive disorder treated with escitalopram or citalopramMeasurement of treatment compliance using a medical device for glaucoma patients associated with intraocular pressure control: a survey.Identification of noncompliant glaucoma patients using Bayesian networks and the Eye-Drop Satisfaction Questionnaire.Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic reviewInitial Treatment: Prostaglandin Analog or Selective Laser TrabeculoplastyType and Frequency of Opioid Pain Medications Returned for Disposal.Accuracy of Patient-reported Adherence to Glaucoma Medications on a Visual Analog Scale Compared With Electronic MonitorsTravoprost in the management of open-angle glaucoma and ocular hypertensionOcular drug delivery for glaucoma management.Glaucoma medication adherence among African Americans: program developmentPaired-eye comparison of medical therapies for glaucoma.Latanoprost in the treatment of glaucoma.Noncompliance with glaucoma medication in Korean patients: a multicenter qualitative study.Patient adherence and persistence with topical ocular hypotensive therapy in real-world practice: a comparison of bimatoprost 0.01% and travoprost Z 0.004% ophthalmic solutions.Adherence with brimonidine in patients with glaucoma aware and not aware of electronic monitoring.Impact of a Brief Educational Intervention on Glaucoma Persistence: A Randomized Controlled Clinical Trial.Adherence of Finnish people with glaucoma to treatment plans and connected factors.Pharmacoepidemiological assessment of adherence and influencing co-factors among primary open-angle glaucoma patients-An observational cohort study.Preservative-free versus preserved latanoprost eye drops in patients with open-angle glaucoma or ocular hypertension.Silicone punctal plugs as an adjunctive therapy for open-angle glaucoma and ocular hypertension.
P2860
Q24197680-53406664-3D47-49D6-A632-9B2BB6309A5FQ24241641-84613B82-3933-4ED9-808D-06341F342D72Q26830201-F2258376-7654-4A87-9881-F20C3997F694Q33300609-110392C7-4D69-4591-A576-D2893C9D3A79Q33492365-8D2C9F5C-AC9D-43D8-A6C6-BCF0C7457611Q33536143-3D52E798-A686-4C08-ACBF-C8A7E0297FFAQ33863644-18556190-B7E5-44A1-906F-C0B508F93418Q33932339-F703A6AB-90E7-4309-B9D5-E19AE9C1C6A3Q34043304-BF95C29B-937C-4584-A281-D76E339E89B0Q34439372-2B5618C4-3B6F-4006-BED9-CCC50D365035Q35327935-5D3E24ED-6784-4382-892C-A1013AE31F8BQ35964378-72E63FAC-4CC4-4630-95E6-E54712719672Q35978808-26D2752E-9E77-45C7-AF4C-4A9F3C606B21Q36055050-AD98CFF5-AAB2-4D12-95F9-540631D7487FQ37236653-513678BF-8FB5-4716-9AAF-A08AE47EF126Q37327814-F5F269E0-6A9A-48D4-98C9-891A38B6EE68Q37582877-CB09605D-F01F-4664-B3D8-75C34C7FFE02Q37801282-DB9199BB-61AF-4310-9C34-883151611A20Q38261310-ED8DF403-49E6-4C57-A72B-2F45E1E77191Q38457427-A7184FCA-5E03-4E26-8C67-0AF3A969B474Q39791012-89BE5EF2-99DC-4011-A38A-5BBD921338BDQ39813661-57C2CAFC-EADA-4DA4-94F2-4C87C6C32521Q40226467-7CA2E991-4246-4F53-B035-66A25E27BF9EQ44327364-E6EF4100-5F0D-4F87-A929-AB3B270868E8Q48252622-A9A1F696-8C47-4574-ACB3-53E404D520CCQ53079997-D87FB6BE-804A-4320-B579-6F4EEFDB991AQ53437093-BABF8B9D-7AEC-4919-BDF2-A279E396F120
P2860
Measurement of persistence and adherence to regimens of IOP-lowering glaucoma medications using pharmacy claims data.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Measurement of persistence and ...... ns using pharmacy claims data.
@ast
Measurement of persistence and ...... ns using pharmacy claims data.
@en
type
label
Measurement of persistence and ...... ns using pharmacy claims data.
@ast
Measurement of persistence and ...... ns using pharmacy claims data.
@en
prefLabel
Measurement of persistence and ...... ns using pharmacy claims data.
@ast
Measurement of persistence and ...... ns using pharmacy claims data.
@en
P2093
P1476
Measurement of persistence and ...... ns using pharmacy claims data.
@en
P2093
Angeline M Carlson
Jacob Wilensky
Lisa S Morris
Richard G Fiscella
P304
P356
10.1016/J.AJO.2005.09.011
P407
P433
P577
2006-01-01T00:00:00Z